XML 52 R56.htm IDEA: XBRL DOCUMENT v3.20.1
Business Segments - Segments in Significant Accounting Policies (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Segment Reporting Information          
Net sales $ 210,739   $ 205,736 $ 614,471 $ 624,112
Depreciation and amortization 8,248   6,875 24,177 20,407
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 18,664   19,515 39,131 62,294
Interest expense, net 3,263   2,931 10,049 8,729
Depreciation and amortization 8,248   6,875 24,177 20,407
Stock-based compensation       1,694 1,694
Acquisition-related costs of goods sold       280  
Foreign currency (gains) losses, net (608)   122 1,895 104
Identifiable assets 776,050 $ 726,671   776,050  
Animal Health          
Segment Reporting Information          
Net sales 138,974   129,189 404,513 399,940
Reconciliation of income before income taxes to Adjusted EBITDA          
Restructure costs   6,281      
Mineral Nutrition          
Segment Reporting Information          
Net sales 56,200   60,653 164,534 177,810
Performance Products          
Segment Reporting Information          
Net sales 15,565   15,894 45,424 46,362
Operating Segments          
Segment Reporting Information          
Net sales 210,739   205,736 614,471 624,112
Depreciation and amortization 7,803   6,436 22,934 19,050
Adjusted EBITDA - Total segments 40,196   39,858 108,563 120,376
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 18,664   19,515 39,131 62,294
Interest expense, net 3,263   2,931 10,049 8,729
Depreciation and amortization 7,803   6,436 22,934 19,050
Restructure costs       425  
Stock-based compensation 565   565 1,694 1,694
Acquisition-related costs of goods sold       280  
Acquisition-related transaction costs       462  
Acquisition-related other       167  
Other, net         (1,506)
Foreign currency (gains) losses, net (608)   122 1,895 104
Adjusted EBITDA - Total segments 40,196   39,858 108,563 120,376
Identifiable assets 656,842 609,412   656,842  
Operating Segments | Animal Health          
Segment Reporting Information          
Net sales 138,974   129,189 404,513 399,940
Depreciation and amortization 6,665   5,571 19,760 16,420
Adjusted EBITDA - Total segments 34,635   33,241 93,534 104,882
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 6,665   5,571 19,760 16,420
Adjusted EBITDA - Total segments 34,635   33,241 93,534 104,882
Identifiable assets 555,917 508,864   555,917  
Operating Segments | Mineral Nutrition          
Segment Reporting Information          
Net sales 56,200   60,653 164,534 177,810
Depreciation and amortization 629   592 1,871 1,805
Adjusted EBITDA - Total segments 4,055   5,287 11,214 11,934
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 629   592 1,871 1,805
Adjusted EBITDA - Total segments 4,055   5,287 11,214 11,934
Identifiable assets 68,693 67,662   68,693  
Operating Segments | Performance Products          
Segment Reporting Information          
Net sales 15,565   15,894 45,424 46,362
Depreciation and amortization 509   273 1,303 825
Adjusted EBITDA - Total segments 1,506   1,330 3,815 3,560
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 509   273 1,303 825
Adjusted EBITDA - Total segments 1,506   1,330 3,815 3,560
Identifiable assets 32,232 32,886   32,232  
Corporate          
Segment Reporting Information          
Depreciation and amortization 445   439 1,243 1,357
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 445   439 1,243 1,357
Corporate costs 10,064   $ 9,850 30,283 $ 28,654
Identifiable assets $ 119,208 $ 117,259   $ 119,208